Family office · 2 deals
Every published round Minderoo Foundation took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| FairSupply | Series A | 22 Dec 2022 | $6.3m | Participant | AgFunderNews, Forbes Australia, SmartCompany, Startup Daily | |
| Fair Supply | Series A | 15 Dec 2022 | $6.3m | Participant | fairsupply.com, Startup Daily, Forbes Australia (15 Jan 2025), Forbes Australia (15 Jan 2025), Tidal Ventures portfolio |
Companies Minderoo Foundation has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Fair Supply | 15 Dec 2022, Series A | 1 | 0 | |
| FairSupply | Climate tech company | 22 Dec 2022, Series A | 1 | 0 |
Fund closes reported for Minderoo Foundation, as distinct from the investments it has made.
Companies Minderoo Foundation has backed that another company then bought. An exit for the holding, not a deal Minderoo Foundation did.
Stories naming Minderoo Foundation. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne biotech ENA Respiratory has begun dosing participants in the second part of its Phase IIa trial of INNA-051; its investor lineup, past government funding awards and BLUE KNIGHT alumni status are recapped.
Melbourne-based ENA Respiratory announced US patent allowances covering its TLR2 agonist platform and a COPD treatment method, strengthening IP protection for its INNA-051 nasal spray candidate now in Phase II testing.
Melbourne biotech ENA Respiratory has begun dosing volunteers in a mid-stage trial of its INNA-051 antiviral spray, aimed at limiting common viral illnesses in at-risk groups.
Profile of Dr Kyle Turner launching the LaunchVic-funded Ochre pre-accelerator for First Nations founders, recalling his dental AI startup Pearlii and his role at a new First Nations venture fund.
Fair Supply, which scores supply-chain ESG risks, announced a round of over $12 million led by Five V Capital with AirTree and QIC, funding growth in Canada and Europe.
Supply-chain ESG compliance software firm Fair Supply has a new investment round led by Five V Capital with AirTree and QIC taking part, as it prepares to expand into Canada and Europe.
Future Generation launched Future Generation Women, a gender-lens fund seeded with $100 million from the Minderoo Foundation, with twelve women portfolio managers deciding investments pro bono; the trust is open to wholesale investors.
Profile of Dr Kyle Turner, who is building Ochre, a LaunchVic-backed pre-accelerator for First Nations founders, and previously raised $3m-plus for dental AI startup Pearlii.
Also Startup Daily·LaunchVic
Profiles Australia's ten wealthiest women from the AFR's new list, alongside Canva's in-progress share sale, a large gift to a global gender-fund vehicle, and one backer's earlier healthtech round.
Roundup of eight local raises totalling roughly $81.5 million: generative AI, sustainable packaging, VR medical training, optical radar, drinks, preventive health and wholesale retail software.
Also Ten13·Startup Daily·Startup Daily·SmartCompany·SmartCompany·Startup Daily·Startup Daily·Startup Daily·Forbes Australia
Tidal Ventures reflects on why it backed Fair Supply, a SaaS platform for ESG supply-chain risk, six months after the deal, praising the founders and naming co-investors Airtree, Minderoo Foundation and QIC.
Techboard's May 2023 roundup of Australian startup funding: 42 private raises topped by Fleet Space's $50m round, two $40m acquisitions, multiple grants, accelerator intakes, and fund news including GiantLeap's $50m fund raise.
Drug developer ENA Respiratory reports positive Phase 2a results for its INNA-051 nasal immunomodulator against influenza, with its Series A backed by Brandon Capital managed funds, the Minderoo Foundation and Uniseed.
FairSupply has closed its Series A funding round led by AirTree Ventures, with Tidal Ventures, Minderoo Foundation and Queensland Investment Corporation participating; the amount was undisclosed and K&L Gates advised on the deal.
ENA Respiratory receives a USD 4.38 million U.S. Department of Defense agreement to develop an intranasal dry powder antiviral; its past Series A backers are also recalled.
Weekly roundup covering 14 startup raises totalling over $260 million, headlined by Synchron's $110 million round, plus Roller's shareholder liquidity payout, Partly's record New Zealand Series A, and several government grants.
Also Startup Daily·Startup Daily·Techboard·SmartCompany·SmartCompany·Startup Daily·SmartCompany·Startup News (WA)·Startup News (WA)
Profile of Cairns startup Rainstick, which uses artificial lightning to boost mushroom growth. It won $20,000 from Dream Ventures, has taken in $200,000, and joined CSIRO's ON Accelerate with nine other teams.
Sydney ESG supply-chain analytics firm FairSupply has raised a $6.3 million Series A led by AirTree, with Tidal Ventures, Minderoo Foundation and QIC investing, following Minderoo's earlier 2021 backing.
Profile of Pearlii founder Kyle Turner, whose Melbourne AI dental-checkup app followed a 2019 Dream Ventures pitch, tracing his journey from Dubbo to Oxford and the company's pivot to dental products.
Seaweed-based plastics maker ULUU has raised AUD 8 million led by Main Sequence, with angels including Karlie Kloss and Kevin Parker taking part, to scale its biodegradable PHA polymer and launch first products.
Secondaries fund SecondQuarter has reached an $83m first close on its second vehicle, aiming past $100m, with founder-angels and Minderoo among new backers; its portfolio includes past sales of ActivePipe and A Cloud Guru.
Also Techboard
Andrew Forrest's private investment company Tattarang is launching Tenmile, a Perth-based $250 million health-tech venture fund that has already backed Emyria and Carina Biotech and partnered with Rock Health.
Antiviral nasal spray developer ENA Respiratory has joined the Blue Knight program run by JLABS and BARDA, the first Australian company selected; background notes recall its Series A backing by Brandon Capital, Minderoo Foundation and Uniseed.
Brandon Capital reports that ENA Respiratory has become the first Australian company chosen for BLUE KNIGHT, a JLABS-BARDA initiative supporting its intranasal broad-spectrum antiviral spray INNA-051.
Advanced Navigation, with Malcolm Turnbull on its board, is seeking $80-135 million; the piece recalls its 2019 $20 million Series A and Minderoo's strategic investment.
Also @AuManufacturing·SmartCompany·SmartCompany·Forbes Australia
ENA Respiratory has begun a Phase 2a influenza-challenge trial in the UK of its INNA-051 antiviral nasal spray; the article also recalls its Series A backing by Brandon Capital, Minderoo Foundation and Uniseed.
ENA Respiratory has begun dosing healthy adults in a UK influenza challenge trial of its INNA-051 antiviral nasal spray, with a COVID-19 study to follow; the release also notes the company's earlier Series A backing.
The founders of the shuttered Stylerunner have raised seed funding for their new shopping app Her Black Book, led by Andrew Hagger with Touch Ventures support; the article recalls Stylerunner's acquisition by Accent Group.
Also SmartCompany·Startup Daily·Startup Daily·Startup Daily·SmartCompany·SmartCompany